Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China flag China · Delayed Price · Currency is CNY
10.08
+0.92 (10.04%)
Nov 2, 2026, 3:00 PM CST

SHA:603108 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-558.96-548.3955.28273.3417.75380.23
Depreciation & Amortization
329.58339.75394.3375.02384.18365.2
Other Amortization
60.0649.8827.7626.3130.8425.11
Loss (Gain) From Sale of Assets
-3.12-3.12-11.46-11.77-6.18-1.73
Asset Writedown & Restructuring Costs
212.61212.6134.1124.5338.223.08
Loss (Gain) From Sale of Investments
-20.79-20.79-109.82-232-137.05-130.72
Provision & Write-off of Bad Debts
196.54196.5481.7188.9198.3751.91
Other Operating Activities
606.01309.72459.28518.77571.48507.49
Change in Accounts Receivable
-70.25-70.25-115.07357.35-2,350-668.83
Change in Inventory
-521.07-521.07-72.5993.37-157.62-360.17
Change in Accounts Payable
748.94748.94-66.98-781.88665.31206.87
Operating Cash Flow
922.96637.22646.95729.72-428.86371.11
Operating Cash Flow Growth
5.19%-1.50%-11.34%--14.74%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-237.1-250.48-229.16-319.88-272.12-301.09
Sale of Property, Plant & Equipment
13.7117.827.9622.8620.8416.44
Cash Acquisitions
---0.18-122.28-18.93-154.45
Divestitures
---99.25--
Investment in Securities
41.16-62.74-198.08-5.13-94.01-1.38
Other Investing Activities
6.1854.54-39.7271.637.3224.9
Investing Cash Flow
-174.66-239.46-460.67-227.34-322.57-415.08

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--125--
Long-Term Debt Issued
-7,7019,47010,0138,4436,447
Total Debt Issued
8,4257,7019,48210,0188,4436,447
Long-Term Debt Repaid
--7,690-8,822-9,835-7,393-5,512
Lease Payments
-----57.42-81.7
Net Debt Issued (Repaid)
-461.5110.92659.83182.851,051935.6
Issuance of Common Stock
--28---
Common Dividends Paid
-238.38-281.35-337.34-377.52-244.17-272.79
Other Financing Activities
-369.56-348.98-258.19-136.64-318.35-567.86
Financing Cash Flow
-1,069-619.492.3-331.32488.1394.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.96-0.32-2.86-0.070.47-1.36
Net Cash Flow
-323.11-221.97275.72171-262.8349.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
685.85386.74417.78409.84-700.9870.03
Free Cash Flow Growth
1.14%-7.43%1.94%---
Free Cash Flow Margin
10.52%5.53%5.03%4.48%-6.68%0.79%
Free Cash Flow Per Share
1.100.640.680.70-1.180.12
Levered Free Cash Flow
1,344530.01257.15219.42-1,062-567.62
Unlevered Free Cash Flow
1,401704.34452.69428.19-863.38-391.42
Free Cash Flow After Leases
685.85386.74417.78409.84-758.39-11.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----9.426.27
Cash Income Tax Paid
309.02350.63548.57546.76509.43488.64
Change in Working Capital
101.03101.03-284.21-333.33-1,906-843.77